Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features.
Trecourt A, Azmani R, Hostein I, Blanchard L, Le Loarer F, Bourdon A, Alame M, Nadaud B, Mayer L, Rebier F, Larmonier C, Moura MS, Soubeyran I, Hartog C, Ray-Coquard I, Treilleux I, Devouassoux-Shisheboran M, Croce S. Trecourt A, et al. Among authors: larmonier c. Mod Pathol. 2023 Oct;36(10):100243. doi: 10.1016/j.modpat.2023.100243. Epub 2023 Jun 10. Mod Pathol. 2023. PMID: 37307879
Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretation.
Fontanges Q, Dubos P, Lesluyes T, Laizet Y, Velasco V, Meléndez B, D'Haene N, Oliva E, Young RH, Mayeur L, Rebier F, Alamé M, Larmonier C, Devouassoux-Shisheboran M, Arnould L, Soubeyran I, Chakiba C, Floquet A, Babin G, Guyon F, Mery E, Le Guellec S, Noël JC, Croce S, Chibon F. Fontanges Q, et al. Among authors: larmonier c. Genes Chromosomes Cancer. 2024 Mar;63(3):e23229. doi: 10.1002/gcc.23229. Genes Chromosomes Cancer. 2024. PMID: 38481055
An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.
Blaye C, Darbo É, Debled M, Brouste V, Vélasco V, Pinard C, Larmonier N, Pellegrin I, Tarricone A, Arnedos M, Commeny J, Bonnefoi H, Larmonier C, MacGrogan G. Blaye C, et al. Among authors: larmonier c. ESMO Open. 2022 Aug;7(4):100502. doi: 10.1016/j.esmoop.2022.100502. Epub 2022 Jun 24. ESMO Open. 2022. PMID: 35759853 Free PMC article.
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity.
Alizadeh D, Wong RA, Gholamin S, Maker M, Aftabizadeh M, Yang X, Pecoraro JR, Jeppson JD, Wang D, Aguilar B, Starr R, Larmonier CB, Larmonier N, Chen MH, Wu X, Ribas A, Badie B, Forman SJ, Brown CE. Alizadeh D, et al. Among authors: larmonier cb. Cancer Discov. 2021 Sep;11(9):2248-2265. doi: 10.1158/2159-8290.CD-20-1661. Epub 2021 Apr 9. Cancer Discov. 2021. PMID: 33837065 Free PMC article.
IDO Targeting in Sarcoma: Biological and Clinical Implications.
Nafia I, Toulmonde M, Bortolotto D, Chaibi A, Bodet D, Rey C, Velasco V, Larmonier CB, Cerf L, Adam J, Le Loarer F, Savina A, Bessede A, Italiano A. Nafia I, et al. Among authors: larmonier cb. Front Immunol. 2020 Mar 5;11:274. doi: 10.3389/fimmu.2020.00274. eCollection 2020. Front Immunol. 2020. PMID: 32194552 Free PMC article.
T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1.
Trad M, Gautheron A, Fraszczak J, Alizadeh D, Larmonier C, LaCasse CJ, Centuori S, Audia S, Samson M, Ciudad M, Bonnefoy F, Lemaire-Ewing S, Katsanis E, Perruche S, Saas P, Bonnotte B. Trad M, et al. Among authors: larmonier c. Biomed Res Int. 2015;2015:891236. doi: 10.1155/2015/891236. Epub 2015 Sep 30. Biomed Res Int. 2015. PMID: 26491691 Free PMC article.
34 results